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ABSTRACT
Many eukaryotic genes are acutely regulated by
extra-cellular signals. The c-fos serum response
element (SRE) mediates transcriptional activation
in response to mitogens through serum res-
ponse factor (SRF)-dependent recruitment of
Elk-1, a mitogen-activated protein kinase (MAPK)-
responsive transcription factor. How subsequent
events at SRE promoters stimulate initiation of
transcription has yet to be fully resolved. Here we
show that extra-cellular signal-regulated kinase
(ERK) and mitogen and stress-activated kinase
(MSK) are recruited to SRE promoter complexes
in vitro and in vivo. Their recruitment in vitro
correlates with Elk-1 binding and for ERK the D
domain/KIM of Elk-1 is specifically involved. In vivo,
recruitment of ERK and MSK is stimulated by
mitogens, correlates with histone H3 phosphor-
ylation and is impaired by Elk-1 knockdown.
Immunocytochemistry and confocal microscopy
reveal that ERK appears to associate to some
extent with initiating rather than elongating RNA
polymerase II. Taken together, our data add to the
body of evidence implying that ERK and related
MAPKs may fulfil a generic role at the promoters of
acutely regulated genes.
INTRODUCTION
Initiation of transcription in eukaryotes is a complex
process involving many proteins. Although their access to
gene promoters requires permissive chromatin structures
controlled by histone-modifying enzymes and chromatin-
remodelling activities (1–3), the expression of numerous
genes is acutely regulated in response to extra-cellular
signals, temporal cues or by factors intrinsic to the cell, for
example mitogens, actin dynamics or circadian rhythms
(4–6). In such instances, transcription factors and
components of the basal transcription machinery can
interact with gene promoters without detectable gene
expression (7). Formation of active pre-initiation com-
plexes, hallmarks of which are phosphorylation of serine 5
(S5) within the carboxy-terminal domain (CTD) of Rpb1,
the largest subunit of RNA polymerase II (RNAPII), local
modiﬁcations to histone H3, including methylation of
lysine 4 (H3K4), phosphorylation of S10 (H3S10) and
acetylation of lysine 14 (H3K14) and RNA synthesis are
detected only in response to upstream stimuli (1,2,8,9).
The expression of the immediate early (IE) genes c-fos
and egr-1 (also known as NGFI-A, zif/268 and Krox24) is
triggered by mitogen-activated protein kinase (MAPK)
signalling (10,11). Such genes are characterised by serum
response elements (SREs) in their promoters, which bind
serum response factor (SRF) and recruit ternary complex
factors such as Elk-1 (12–14). Elk-1 is phosphorylated by
ERKs (also JNK/SAPKs and p38MAPK isoforms) and
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c-fos expression, events following Elk-1 phosphorylation
are less well understood. It has been proposed that upon
phosphorylation Elk-1 adopts an active conformation
(15), in which it participates in transcriptional activation
through co-activators including MED23 (TRAP150beta/
CRSP130/Sur2) and p300/CBP (16–19). More recently, it
has been shown that inactive Elk-1 is sumoylated and that
upon phosphorylation of Elk-1 the Sumo E3 ligase
PIASxa, by desumoylating Elk-1 and disengaging asso-
ciated histone deacetylases (HDACs), serves as an Elk-1
co-activator (20,21). In these scenarios, the role of ERK is
restricted to Elk-1 phosphorylation.
Several reports have described the association of
yeast MAPKs with speciﬁc gene promoters (22–25).
Furthermore, human p38 was recently shown to occupy
gene promoters during myogenesis (26) and ERK was
found in a complex with the progesterone receptor on the
MMTV promoter (27). These ﬁndings are consistent with
the proposal that MAPKs may be frequent occupants of
signal-regulated gene promoters (25,28) and imply that
they serve additional roles during transcriptional activa-
tion besides the phosphorylation of target transcription
factors (29–31).
We studied pre-initiation complexes (PICs) on immo-
bilized, mitogen-responsive SRE promoters and found
that both ERK and MSK were recruited to SRE-
dependent PICs in a mitogen- and Elk-1-dependent
manner. Reconstitution experiments with recombinant
proteins indicated that the D-domain/kinase interaction
motif (KIM) of Elk-1 was essential for ERK recruitment.
Chromatin immunoprecipitation (ChIP) assays conﬁrmed
the mitogen-dependent phosphorylation of Elk-1 and
recruitment of ERKs and MSK1 to the c-fos and egr1
promoters in cells. However, co-localization of phospho-
ERK (pERK) with phospho-Elk-1 (pElk-1) in mitogen-
stimulated cells was low and exceeded signiﬁcantly by
co-localization of pERK with RNAPII in which the CTD
was phosphorylated on S5 (pS5-CTD). This implies that
the interaction between Elk-1 and ERK is transient and
that ERK may subsequently associate with and phosphor-
ylate other targets within PICs, thereby contributing
directly to the transcriptional activation of mitogen-
responsive genes.
MATERIALS AND METHODS
Cell cultureand nuclear extractpreparation
For nuclear extracts, HeLa cells were grown in suspension
in Joklik’s MEM supplemented with 10% fetal calf serum
(FCS), 100Uml
 1 penicillin, 100mgml
 1 streptomycin,
1% non-essential amino acids, 2mM L-glutamine. Cells
were serum-starved for 42–44h in medium containing
0.5% FCS and either harvested directly or after stimula-
tion with 20% FCS for 10min. Nuclear extracts were
prepared from 1.5 10
9 cells, essentially as described (32).
For ChIP assays and immunocytochemistry, HeLa
cells were grown as monolayers, on plastic or glass,
respectively, in DMEM supplemented with 10%
FCS, 2mM L-glutamine, 100Uml
 1 penicillin and
100mgml
 1 streptomycin. For reporter assays, NIH3T3
cells were grown in DMEM supplemented with 10% FCS,
2mM L-glutamine, 100Uml
 1 penicillin and 100mgml
 1
streptomycin.
Luciferase reporter assays were performed as previously
described (33), and in vitro transcription assays were
performed as described elsewhere (34).
RNAi knockdown was performed with siRNA from
Ambion, reverse-transfected into HeLa cells with the
siPORT NeoFX transfection agent (Ambion) according to
the manufacturer’s instructions.
Reagents,plasmids and antibodies
Streptavidin-coated magnetic beads were from Dynal
(Dynabeads M-280 Streptavidin). The generic oligonu-
cleotides for promoter synthesis by PCR were:
b-profor (biotinylated) 50-CTGCAGGTCGACTCT
AGC;
g-prorev 50-AGTATGTGAGAGTGTAAAAAAGGG
CCAAGTGC.
The plasmid pE4-38 CAT, containing the basal
promoter from the adenovirus 2 E4 promoter was used
to generate the TATA promoter (35). The plasmids pSRE-
CAT and pSIDE-CAT, containing a single SRE or a
mutant thereof that fails to bind Elk-1 (SIDE) inserted
upstream from the TATA box in E4-38 CAT, were used
to generate SRE and DSE promoters, respectively. For
reporter assays, analogous pGL3-based luciferase con-
structs containing a single SRE or DSE upstream from
the adenovirus 2 E4 basal promoter were transfected alone
or with expression vectors for active RhoA (L63) or
C-Raf (259D).
Plasmids containing G-free cassettes used for in vitro
transcription analyses, pML(C2AT), pTATA-B7 and
pWT-TATA-(C2AT)19 (SRE) were provided by R. A.
Hipskind and have been described elsewhere (34).
Plasmids used to express his-tagged Elk-1 FxFP
mutants (FxLA and dbl) were derived from pQE-Elk-
his6 and pQE-ElkD, respectively (36) by site-directed
mutagenesis.
Antibodies used were as follows: the ElkC and JNK/
SAPK are rabbit polyclonal antibodies raised against
recombinant proteins; the SRF (H-300), ERK1/ERK2
goat (C-14), MSK1 (H-65), RSK2 mouse monoclonal
(E-1), TBP (N-12), p300 (C-20), RAP74 (C-18), MED1
(C-19), Elk-1 (I-20) and pElk-1 mouse monoclonal (B-4)
were from Santa Cruz; the MSK1 sheep polyclonal (for
immunoblots) and HDAC1 (2E10) and HDAC2 (3F3)
mouse monoclonals and phospho/acetyl-H3S10K14
rabbit polyclonal were from Upstate; the pERK rabbit
monoclonal (20G11) and p38 (9212) were from Cell
Signaling; the MED23 mouse monoclonal (D27) was from
BD Biosciences; the RNAPII pS5-CTD (H14), pS2-CTD
(H5) and RNAPII-CTD (8WG16) mouse monoclonals
were from Abcam; the AlexaFluor 488 goat anti-mouse/
AlexaFluor 568 goat anti-rabbit were from Invitrogen,
Molecular Probes.
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Streptavidin-coated magnetic beads (300mg), pre-washed
in binding buﬀer (1M NaCl, 10mM Tris pH 7.4, 0.2mM
EDTA), were incubated with biotinylated promoter
fragment (20–25pmol) in binding buﬀer for 1h at RT,
then washed twice in binding buﬀer and twice in
transcription buﬀer (12mM HEPES pH 8.0, 12%
glycerol, 60mM KCl, 0.12mM EDTA, 7.5mM MgCl2,
1mM DTT, 0.5mM PMSF). Nuclear extract (300mg) was
pre-incubated with salmon sperm DNA (3mg), poly(dIC)
(3mg) in transcription buﬀer (200ml) on ice for 15min.
Immobilized promoters and nuclear extract were com-
bined and incubated at 308C for 45min with gentle
shaking. PICs were washed thrice in transcription buﬀer
with 0.05% NP-40 and proteins were subsequently eluted
in 1M NaCl at 308C for 15min.
Reconstituted promoter-binding assays with
recombinant proteins
Methods used to generate recombinant coreSRF, his-
tagged rElk-1, inactive and active rERK2 have all been
described (37,38). For in vitro phosphorylation, rElk-1
(1mg) and mutant derivatives were incubated with active
rERK2 (0.5mg) in PP buﬀer (25mM Tris pH 7.2, 10mM
MgCl2, 1mM DTT, 0.1mM EGTA, 0.1mM Na3VO4,
1mM okadaic acid, 250mM ATP) at 378C, after which
Elk-1 proteins were examined by SDS–PAGE and
immunoblotting. For promoter binding Elk-1 (3mg) and
coreSRF (0.75mg) were pre-incubated in PP buﬀer (4mM
HEPES pH7.5, 150mM NaCl, 5mM MgCl2, 0.2mM
EDTA, 0.1mM Na3VO4, 0.1% Triton X-100, 40mM
b-glycerophosphate and 0.5mM DTT) containing
poly(dIC) and sheared herring sperm DNA (60mgml
 1
each) on ice for 10min prior to addition of 12.5mgml
 1
biotinylated SRE promoter template, incubation for
10min at 228C, addition of ERK proteins (2mg) and
further incubation for 20min at 228C. Streptavidin-coated
magnetic beads (100mg), pre-incubated in BP buﬀer
containing BSA (1mgml
 1) were incubated with com-
plexes for 1h, washed three times in BP buﬀer and eluted
in 1M NaCl for 15min at 228C. Proteins were examined
by SDS–PAGE and immunoblotting.
Chromatin immunoprecipitation assays
ChIP assays were performed as described (39) with
modiﬁcations. HeLa cells were incubated with 1%
formaldehyde at 378C for 10min, washed twice in ice-
cold PBS with 125mM glycine, 1mM EDTA, 1mM
PMSF and collected in 1ml of ice-cold PBS. Cell pellets
were re-suspended in lysis buﬀer (50mM Tris–HCl pH
8.0, 1% SDS, 10mM EDTA, 1  protease inhibitor
cocktail) and sonicated to produce DNA fragments of
200–500bp. Lysates were diluted 10-fold in 20mM Tris–
HCl, pH 8.0, 1% Triton X-100, 2mM EDTA, 150mM
NaCl, 1  protease inhibitor cocktail and incubated with
antibodies over night at 48C. Immune complexes were
incubated with sheared salmon sperm DNA for 1h at 48C
before the addition of protein G Sepharose beads,
pre-blocked with BSA and further incubation for 1h.
Immunoprecipitates were washed with TSE I (20mM
Tris–HCl pH 8.0, 0.1% SDS, 1% Triton X-100, 2mM
EDTA, 150mM NaCl); TSE II (20mM Tris–HCl pH 8.0,
0.1% SDS, 1% Triton X-100, 2mM EDTA, 500mM
NaCl); Buﬀer III (10mM Tris–HCl pH 8.0, 1% NP-40,
1mM EDTA, 1% deoxycholate, 0.25M LiCl) and twice
with TE buﬀer. DNA–protein complexes were eluted twice
with 1% SDS in 0.1M NaHCO3. Eluates were pooled and
cross-links reversed at 658C for 6h. After proteinase K
digestion for 1h at 458C, DNA fragments were puriﬁed
with a PCR puriﬁcation kit (Qiagen). Primers for the
human c-fos promoter ( 473 to  276) were: 50-
GGGTCCGCATTGAACCAGGTGC (forward) and 50-
GCCGTGGAAACCTGCTGACGCA (reverse); the
human c-fos gene (+1711 to +1865) primers were: 50-
CTGGGAACTCGCCCCACCTGTGTC (forward) and
50-CACTGCAGGTCCGGACTGGTCGAG (reverse).
Primers for the human egr1 promoter were as published
elsewhere (40); the egr-1 gene (+1066 to +1305) primers
were 50-ATTTGCGTCAGCTGTTGTTG (forward) and
50-CAGCACCTTCTCGTTGTTCA (reverse). For PCR
quantiﬁcation, Aida software was used to measure band
intensities from digital gel images. Values represent
averages from three independent experiments (error
bars=SD).
Immunocytochemistry, confocalmicroscopy and
image analysis
Cells were ﬁxed directly in 2% formaldehyde in PBS for
15min at RT, permeabilized for 10min in 0.5% Triton
X-100 in PBS, incubated for 10min in 100mM glycine in
PBS, 10min in 10% BSA and 5min in PBS containing
0.5% BSA (PBS/BSA). Incubations with primary anti-
bodies (mouse monoclonal a-pElk-1 (B-4, Santa Cruz);
rabbit monoclonal a-pERK (20G11) were carried out in
PBS/BSA for 1h at RT [for the mouse monoclonal (H14)
to RNAPII at 48C over night]. Cover slips were subse-
quently washed four times for 5min in PBS/BSA and
incubated with secondary antibodies (AlexaFluor 488
goat anti-mouse, and AlexaFluor 568 goat anti-rabbit)
for 1.5h in PBS/BSA at RT. Cover slips were washed twice
for 5min in PBS/BSA, twice for 5min in PBS, for 10min in
PBS containing 0.4mgml
 1 Hoechst 33258 and 10min
in PBS. Cover slips were mounted in Vectashield (Vector
Labs).
Images were collected with a Leica SP2 Confocal Laser
Scanning Microscope (CLSM), equipped with a Leica
IRBE inverted ﬂuorescence microscope (63  objective,
oil-immersion, NA 1.3). The green ﬂuorescence of
AlexaFluor 488 or GFP was excited at a wavelength of
488nm and detected at 498–550nm using a spectro-
photometer detection system; AlexaFluor 568 labelled
proteins were excited at 561nm and detected at
580–667nm. In all cases, the pinhole was equivalent to
1 Airy disk. Images were collected as single optical
sections, averaged 20 times, displayed using the associated
Leica SP2 software and compiled using Adobe Photoshop.
For image analysis, red and green-channel confocal
images were combined into a dual-colour image in Leica
2596 Nucleic Acids Research, 2008, Vol. 36, No. 8SP2 software. Lines were drawn through the nuclei and
red and green channel line-scan intensity proﬁles were
obtained. The correlation between the red and the green
intensities was determined according to Pearson’s correla-
tion coeﬃcient (Rp). For each nucleus examined, ﬁve
independent line-scans were performed and averages were
derived from 10 values.
RESULTS
Generation and validationof PICs on SRE promoters
Three simple promoters were used to produce PICs in
HeLa cell nuclear extracts (Figure 1a). The SRE promoter
consisted of a single copy of the c-fos SRE, which is
known to bind SRF and Elk-1 in a ternary complex (7),
centred 27-bp upstream of a TATA element. The DSE
promoter carried a mutated ETS-binding site; the TATA
promoter lacked an activating element altogether.
Complexes recruited to these promoters in HeLa nuclear
extracts contained transcription factors as anticipated.
Thus SRF, Elk-1 and TBP bound to the SRE promoter
(Figure 1b, lanes 2 and 9); SRF and TBP but not Elk-1
bound to the DSE promoter (lanes 3 and 10) whereas
neither Elk-1 nor SRF bound to the basal TATA
promoter (lanes 4 and 11), irrespective of prior mitogen
stimulation of the cells, as indicated by ERK and Elk-1
phosphorylation (Figure 1c). Binding of SRF to the SRE,
Figure 1. Functional analysis of simple promoters used to derive pre-initiation complexes. (a) Diagram showing DNA elements present in promoter
templates. The SRE sequence is derived from the human c-fos promoter with the CArG box centred 27-bp upstream of the TATA box. In the DSE
promoter the Ets-binding site is inactivated by a triple point mutation and the TATA promoter lacks an upstream element. (b) Nuclear extracts from
unstimulated (lanes 1–7) or serum-stimulated (lanes 8–14) cells were used for PIC assembly on SRE (lanes 2 and 9), DSE (lanes 3 and 10) or TATA
(lanes 4 and 11) templates. Complexes were isolated, washed and resolved by SDS–PAGE for analysis by immunoblotting with antibodies against
Elk-1 (upper panel), SRF (middle) and TBP (lower). Inputs were resolved in lanes 1 and 8; ﬂow through fractions in lanes 5–7 and 12–14. (c) Time
course of Elk-1 and ERK phosphorylation in response to serum stimulation of HeLa cells. (d) NIH3T3 cells were transfected with SRE-Luc3 or
DSE-Luc3 alone or with expression vectors for active RhoA or C-Raf, as indicated. Data are from one representative experiment with triplicate
points (error bars=SD). (e) Circular and linear templates, as indicated, containing an SRE (lanes 1–4 and 9–12) or basal promoter (TATA) (lanes
5–8 and 13–16), were incubated at two diﬀerent concentrations along with a control template derived from the adenovirus 2 major late promoter
(MLP) in transcription reactions with nuclear extracts from serum-starved ( ) or stimulated (+) cells. RNA transcripts from SRE templates are
indicated with arrows. (f) Nuclear extracts from unstimulated (lanes 1–7) or serum-stimulated (lanes 8–14) cells were used for PIC assembly on SRE
(lanes 2 and 9), DSE (lanes 3 and 10) or TATA (lanes 4 and 11) templates. Complexes were isolated, washed and resolved by SDS–PAGE for
analysis by immunoblotting with antibodies against p300 (upper panel), MED1, MED23, RAP74, HDAC1 and HDAC2 (lower panel). Inputs were
resolved in lanes 1 and 8; ﬂow through fractions in lanes 5–7 and 12–14.
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earlier (41).
Functionality of these simple promoters in vivo was
conﬁrmed by reporter assays. The SRE was preferentially
activated by C-Raf, a component of the ERK cascade,
while the DSE promoter responded better to RhoA, which
triggers an Elk-1 independent pathway involving the SRF
co-activator MAL/MKL-1 (42–44) (Figure 1d). In in vitro
transcription assays, RNA was transcribed accurately
from both circular (Figure 1e, left panel) and linear (right
panel) templates. However, similar levels of transcription
were achieved from both SRE and TATA promoters and
regardless of mitogen stimulation, as observed previously
(45). Importantly, this result conﬁrmed that the promoters
recruit transcriptionally competent PICs in vitro.
Next, we examined PIC occupancy by transcriptional
co-activator proteins potentially aﬀected by mitogens. The
histone acetyl transferase (HAT) p300 was detected only
in PICs formed on SRE and DSE promoters in mitogen-
stimulated nuclear extracts (Figure 1f, lanes 9 and 10)
(16,19). In contrast to HATs, HDACs have been reported
to dissociate from activated transcription factors upon
stimulation (46,47), but both HDAC1 and HDAC2 were
detected in PICs formed on the SRE, DSE and TATA
promoters irrespective of mitogen stimulation (lower
panel) (47,48). Likewise, the TFIIF subunit RAP74,
which interacts with SRF (49), MED1 (also known as
TRAP220 or PPAR-binding protein), a component of the
DRIP/CRSP/mediator co-activator complex required for
transcriptional activation by nuclear hormone receptors
(e.g. thyroid hormone receptor) and other transcription
factors (50,51), and MED23, another mediator subunit
shown to undergo phosphorylation-dependent interac-
tions with Elk-1 (17,18), were on all three promoters and
irrespective of stimulation. This recruitment pattern
suggests that basal transcription factors and the mediator
complex can associate with SRE promoters prior to
mitogen stimulation, which is consistent with published
data (52) (see below). On the basis of this data, we
concluded that the characteristics of the in vitro PICs were
suﬃcient to warrant further characterization of their
composition.
Mitogen-dependentrecruitment ofERK and MSKto
SREpromoter complexes
Transcriptional activation by Elk-1 in response to mito-
gens is contingent upon its phosphorylation on multiple
sites by ERK and the consequent recruitment of
co-activators such as p300 to SREs (12–14). Although
active ERK is known to accumulate in the nuclei of
mitogen-stimulated cells (53,54) the underlying mecha-
nism is incompletely understood. However, several reports
of MAPKs associating with gene promoters have
appeared recently (22–27).
Among the proteins present in PICs assembled in vitro
we identiﬁed ERK. As shown in Figure 2a, ERK was
absent from PICs formed on SRE, DSE or TATA
promoter templates in extracts from unstimulated cells
(upper panel, lanes 2–4) but present in PICs formed on
SRE promoters in mitogen-stimulated extracts (lane 9).
ERK was not detected on DSE or TATA promoter
templates (lanes 10 and 11). Immunoblotting for phospho-
ERK conﬁrmed bound ERK to be active. Neither JNK/
SAPK nor p38MAPK (lower panels) was detected in any
of the PICs, regardless of promoter template or mitogen
stimulation. These data suggest that mitogens stimulate
recruitment of active ERK into PICs assembled on SRE
promoter templates.
The related mitogen and stress-responsive kinase
(MSK) and ribosomal S6 kinase (RSK) are MAPK-
dependent protein kinases. Both have been linked to the
promoters of IE genes such as c-fos and implicated in
histone H3S10 and H3S28 phosphorylation in response to
EGF (55–58). Mutations in the RSK2 gene are linked to
Coﬃn–Lowry syndrome (59). Although neither kinase
was detected in PICs assembled in unstimulated extracts,
we consistently observed the association of MSK but not
RSK with SRE PICs formed in extracts from serum-
stimulated cells (Figure 2b).
Recruitment of ERKto SRE promoter requires docking
motifs in Elk-1
As the SRE binds Elk-1 whereas the DSE does not, we
used recombinant proteins to test whether Elk-1 recruited
ERK to the SRE. In the absence of other proteins or in the
presence of the DNA-binding domain of SRF (core
SRF)
alone, neither inactive nor active ERK2 was recruited to
an immobilized SRE promoter (Figure 3a, lanes 2, 3, 7
and 8). When recombinant Elk-1 was included in the
Figure 2. Pre-initiation complexes on SRE promoters contain ERKs
and MSK1. (a) Nuclear extracts from unstimulated (lanes 1–7) or
serum-stimulated (lanes 8–14) cells were used for PIC assembly on SRE
(lanes 2 and 9), DSE (lanes 3 and 10) or TATA (lanes 4 and 11)
templates. Complexes were isolated, washed and resolved by SDS–
PAGE for analysis by immunoblotting with antibodies against ERKs
(upper panel), phospho-ERKs, JNKs and p38 (lower). Inputs were
resolved in lanes 1 and 8; ﬂow through fractions in lanes 5–7 and 12–
14. (b) As in (a) except with antibodies against MSK1 (upper panel)
and RSK2 (lower panel).
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was recruited into SRE complexes (lanes 5 and 6).
Analogous experiments performed with recombinant
MSK1 failed to yield promoter complexes containing
MSK (data not shown).
ERK interactions with their regulators and substrates
are governed by docking domains (60,61). Within Elk-1
the D domain/KIM and the FxFP motif are important for
eﬃcient phosphorylation of Elk-1 (62,63). Versions of
Elk-1 with MAPK docking sites mutated or removed
(Figure 3b and c) were used to test their contribution to
ERK recruitment into SRE promoter complexes. In a
kinase assay with active ERK2, in which phosphorylation
of S383 was assessed with a phospho-speciﬁc antibody
(Figure 3d) deletion of the D-box/KIM (Elk-D) had
only a minor eﬀect on S383 phosphorylation whereas
mutation of the FxFP site (FxLA) reduced S383
phosphorylation by ERK2 up to 90%. An Elk-1 mutant
lacking both docking sites (dbl) was not phosphorylated
by ERK2 under these conditions. When the Elk-1 mutants
were tested for the ability to recruit ERK into SRE
complexes recruitment of active ERK2 was impaired by
mutation of the FxFP motif (Figure 3e, compare lanes 4
and 8) and lost with the D box/KIM mutant (lanes 6 and
10). Thus, although the FxFP motif is necessary for
eﬃcient phosphorylation of Elk-1 residues critical for
activation, only the D box/KIM appears to be essential
for ERK recruitment to the SRE.
Mitogen-dependentrecruitment ofERK and MSKto c-fos
andegr-1 promoters
To look for recruitment of kinases to mitogen-responsive
gene promoters we examined c-fos promoter complexes by
ChIP assay and semi-quantitative PCR (Supplementary
Figure S1). First, we used an antibody against Elk-1 (I-20)
used previously in such assays (64,65). In serum-starved
cells, Elk-1 was detected on the c-fos promoter, but not
within the c-fos gene. However, upon TPA stimulation the
signal was lost, returning over 1h (Figure 4a, upper
panels, lanes 9–12). In contrast, a second antibody (ElkC)
detected Elk-1 on the promoter throughout the time
course (lanes 13–16). When cells were treated with the
MEK inhibitor U0126, both antibodies detected Elk-1at
the c-fos promoter before and during mitogen stimulation
(Figure 4a, middle panels). A third, phospho-speciﬁc
Elk-1 antibody (ElkpS383) detected phospho-Elk-1 on the
promoter transiently after TPA stimulation, which corre-
lated with the time course of Elk-1 phosphorylation in
mitogen-stimulated cells (Figure 1c and data not shown).
Further experiments conﬁrmed that the I-20 antibody
we used detected only unphosphorylated Elk-1 (data
not shown). Taken together, these results indicate that
unphosphorylated Elk-1 occupies the c-fos SRE prior to
stimulation and that phosphorylated Elk-1 is present
transiently following mitogen stimulation.
The presence of mediator components in the in vitro
PICs (Figure 1f) prompted us to examine their behaviour
in similar experiments. Both MED1 and MED23 were
detected on the c-fos promoter both before and during
mitogen stimulation (Figure 4b, lanes 9–12). An increase
Figure 3. Elk-1 recruitment of ERK to SRE in vitro is dependent on D
domain. (a) The SRE promoter template was incubated with
recombinant core
SRF alone (lanes 1–3), core
SRF and rElk-1 (lanes
4–6) or neither (lanes 7 and 8) along with inactive rERK (lanes 2, 5 and
7) or active rERK (lanes 3, 6 and 8). Complexes were isolated on
magnetic beads and analysed by immunoblotting. The arrows indicate
ERK2 (upper panel) and Elk-1 (lower). (b) Representation of Elk-1
including DNA-binding domain (ets), SRF interaction domain (B),
suppressor domain (S), docking (D) domain, trans-activation domain
(C) and FxFP motif (f). Sites of deletion/mutation are indicated in the
corresponding mutants. (c) SDS–PAGE analysis of recombinant
proteins used in this study, as indicated. Full-length proteins and
core
SRF are identiﬁed by arrowheads. (d) Recombinant Elk-1 and the
deletions represented in (b) were incubated with active rERK2 for the
times indicated and phosphorylation of Ser383 was analysed by SDS–
PAGE and immunoblotting with a phospho-speciﬁc antibody (upper
panel). Elk-1 substrates were controlled with an antibody against Elk-1
(lower panel). N.B. phosphorylation of Elk-1 results in electrophoretic
separation of isoforms that increases the signal on the membrane.
Relative amounts of Elk-1 proteins in the assay are apparent in lanes 1,
4, 7 and 10. (e) The SRE promoter template was incubated with
recombinant core
SRF alone (lanes 1 and 2), with core
SRF and rElk-1
(lanes 3 and 4), rElk-D (lanes 5 and 6), rElk-FxLA (lanes 7 and 8),
rElk-dbl (lanes 9 and 10) or without (lanes 11 and 12) along with
inactive rERK2 (lanes 1, 3, 5, 7, 9 and 11) or active rERK2 (lanes 2, 4,
6, 8, 10 and 12). Complexes were isolated on magnetic beads and
analysed by immunoblotting with antibodies against ERK (upper
panel) and Elk-1 (lower panel).
Nucleic Acids Research, 2008, Vol. 36, No. 8 2599in MED23 was not apparent but a modest stimulation of
MED1 binding was observed, as reported previously for
the egr1 promoter (52).
In parallel analyses, we looked for ERK and MSK at
the c-fos promoter. In both cases, we detected increased
association upon stimulation with 100ngml
 1 TPA,
whereby recruitment of ERK appeared to precede that
of MSK (Figure 4c, lanes 9–12 and 13–16). When cells
were stimulated with 500ngml
 1 TPA for 15min or 20%
FCS for 30min, recruitment of ERK and MSK to the
c-fos promoter was pronounced (Figure 4d, lanes 8, 9, 11
and 12). Under these circumstances, we observed a
3–4-fold increase in ERK and MSK occupancy at the
c-fos promoter following stimulation (Figure 4e).
A consequence of MSK activation is H3S10 phos-
phorylation [often with acetylation of an adjacent lysine
(66)], which has been detected in the vicinity of
mitogen-responsive gene promoters and correlated with
transcriptional activity (57,58,67). We therefore looked for
H3S10 phosphorylation in response to TPA and serum at
the c-fos promoter. As shown in Figure 4f, H3S10
phosphorylation was signiﬁcantly greater over the pro-
moter than on the c-fos gene and increased following
mitogen stimulation (lanes 8 and 9) in parallel with MSK
recruitment.
Next, we looked if these observations extended to other
IE gene promoters. TPA stimulation transiently increased
the level of phospho-Elk-1at the egr-1 promoter
(Figure 5a, lanes 9–12), which correlated with an increase
in MED1 recruitment (lanes 13–16). At the same time,
recruitment of ERK and MSK to the egr-1 promoter also
increased (Figure 5b) and higher concentrations of TPA
or serum were more eﬀective at stimulating ERK
recruitment (Figure 5c). TPA also stimulated H3S10
Figure 4. ERKs and MSK1 are recruited to c-fos promoter in response to mitogen stimulation. (a) HeLa cells were serum starved or starved and
stimulated with TPA (100ngml
 1) for the times indicated, with (+) or without ( ) treatment with U0126. Binding of Elk-1 to the c-fos promoter
was then determined by chromatin immunoprecipitation (ChIP). PCRs containing primer pairs amplifying a promoter region containing the SRE
(upper panel) or a region of the gene (lower panel) were performed after immunoprecipitation of DNA/promoter complexes with the Elk-1
antibodies indicated. (b) As in (a) except binding of mediator components to the c-fos promoter was determined by chromatin immunoprecipitation
(ChIP) with antibodies against MED1 and MED23. (c) As in (a) except immunoprecipitations were performed with ERK (lanes 9–12) or MSK1
antibodies (lanes 13–16). (d) As in (c) except cells were treated with 500ngml
 1 TPA for 15min (T) or 20% FCS for 30min (S). (e) Quantiﬁcation of
ERK and MSK binding in three independent experiments similar to those presented in (d). Error bars=SD. (f) As in (d) except
immunoprecipitations were performed with a histone H3 pS10 AcK14 antibody (lanes 7–9).
2600 Nucleic Acids Research, 2008, Vol. 36, No. 8phosphorylation over the egr-1 promoter but not over the
gene (Figure 5d). Taken together, these data indicate that
ERK and MSK are recruited to the c-fos and egr1
promoters following mitogen stimulation of HeLa cells.
Localization ofElk-1, ERK and RNAPII inHeLa nuclei
Mitogens were ﬁrst shown to stimulate nuclear accumula-
tion of ERKs by immuno-staining and confocal micro-
scopy (53). We used a similar approach to look for nuclear
co-localization of active ERK and Elk-1. Immunoblotting
experiments conﬁrmed that two pERK antibodies
detected only pERKs (predominantly ERK2 in HeLa
cell lysates). A rabbit pElk-1 antibody detected pElk-1 in
lysates from mitogen-stimulated cells but also high
molecular weight species in both stimulated and unstimu-
lated cells. However, a mouse monoclonal only detected
phospho-isoforms of Elk-1 (Supplementary Figure S2a).
As a further test of antibody ﬁdelity, quiescent or
mitogen-stimulated HeLa cells transfected with a vector
for a GFP-Elk-1 fusion protein were ﬁxed and stained for
pElk-1. A high coincidence of GFP ﬂuorescence and
immunostaining was observed in the mitogen-stimulated
cells, conﬁrming the speciﬁcity of the pElk-1 antibody
(Supplementary Figure S2b and c).
In serum-starved cells weak, punctate pElk-1 staining
was seen within the nuclei whereas there was little
staining of pERK (Figure 6a, left panels). Following
mitogen stimulation, strong, punctate pElk-1 staining
was seen, coincident with the appearance of nuclear
pERK (Figure 6a, right panels and Figure 6b). No
staining was observed with either secondary antibody,
either alone or when incubated with unmatched
primary antibodies (data not shown). When the pElk-1
and pERK images were merged, coincident staining
was apparent although not extensive (Figure 6b left, see
inset in middle quadrant), showing that active ERK does
not associate predominantly with pElk-1 within the
nucleus.
To see if the locations of pElk-1 and pERK corre-
sponded to active promoters we looked for co-localization
of each with RNAPII pS5-CTD as a marker for sites of
transcriptional initiation. The distribution of RNAPII
pS5-CTD corresponded with that reported previously
(Figure 6b) (68). In the case of pElk-1, we saw
co-localization with RNAPII pS5-CTD (Figure 6b,
centre panels). For pERK, foci of coincident staining
were even more apparent in the nuclei of mitogen-
stimulated cells (right-hand panels).
Figure 5. ERKs and MSK1 are recruited to egr-1 promoter in response to mitogen stimulation. (a) HeLa cells were serum starved or starved and
stimulated with TPA (100ngml
 1) for the times indicated and the presence of pElk-1 and MED1at the egr-1 promoter was determined by chromatin
immunoprecipitation (ChIP). PCRs containing primer pairs amplifying a promoter region containing the promoter proximal SRE (upper panel) or a
region of the gene (lower panel) were performed after immunoprecipitation of DNA/promoter complexes with the antibodies indicated. (b) As in (a)
except immunoprecipitations were performed with ERK (lanes 9–12), MSK1 (lanes 13–16) or Elk-1 (lanes 17–20) antibodies. (c) As in (b) except cells
were treated with 500ngml
 1 TPA for 15min (T) or 20% FCS for 30min (S). (d) As in (c) except immunoprecipitations were performed with a
histone H3 pS10 AcK14 antibody (lanes 7–9).
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scan analyses were performed (69). For GFP-Elk-1 and
pElk-1, we obtained a mean Pearson’s correlation
coeﬃcient of 0.79, consistent with a high degree of
coincident staining (Supplementary Figure S2c). In con-
trast, the mean value for pERK and pElk-1 was 0.13,
which was exceeded by the apparent co-localization of
both proteins with RNAPII pS5-CTD (means of 0.33 and
0.42, respectively, see Figure 6c). Analogous experiments
performed with antibodies speciﬁc for CTD phosphory-
lated on serine 2 (pS2-CTD) and total RNAPII-CTD
showed that Elk-1 co-localized preferentially with
RNAPII carrying pS5-CTD, i.e. engaged in transcrip-
tional initiation (Supplementary Figure S2d). Taken
together, these observations indicate that pElk-1 and
pERK localize more readily with active RNAPII than
with each other, suggesting that the interaction between
pERK and Elk-1 in mitogen-stimulated cells is transient.
Elk-1 knockdownprevents recruitment ofERK and
MSK toc-fosand egr-1 promoters
If Elk-1 is involved in the recruitment of ERK and MSK
to SRE promoters, removal of Elk-1 from cells should
Figure 6. Nuclear pERK co-localises with RNAPII pS5-CTD. (a) HeLa cells were serum-starved or starved and stimulated with TPA (100ngml
 1)
for 10min. Cells were ﬁxed, stained with antibodies as indicated and examined by confocal microscopy. (b) Higher magniﬁcation images of
TPA-stimulated cells stained for pElk-1 and pERK (left column), pS5-CTD and pElk-1 (centre column) and pS5-CTD and pERK (right column).
Insets within merged panels represent 3-fold digitally enlarged areas within the respective nuclei. (c) Line-scan analyses of the images shown in (b).
Pearson’s correlation coeﬃcients (Rp) for the line scans shown are indicated. Mean Rp values (n=10) for coincident staining were: for pElk-1 and
pERK 0.13; for pElk-1 and RNAPII pS5-CTD 0.33; for pERK and RNAPII pS5-CTD 0.41.
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assays were performed with cells in which Elk-1 expression
was ﬁrst reduced by RNAi (70). As shown in Figure 7a, a
combination of two siRNA species reduced Elk-1 expres-
sion in HeLa cells by  90%. Parallel analyses were then
performed on mock and siRNA-transfected cells that were
starved and stimulated with TPA. As anticipated, Elk-1
knockdown caused a signiﬁcant decrease in Elk-1at the
c-fos promoter (Figure 7b, lanes 9–12). Whereas TPA
induced the recruitment of both ERK and MSK to the
c-fos promoter in control cells (lanes 14 and 18), Elk-1
knockdown prevented the recruitment of both kinases
(lanes 16 and 20). Furthermore, Elk-1 knockdown also
prevented ERK and MSK recruitment to the egr-1
promoter (Figure 7c). Taken together, these results
demonstrate that Elk-1 is required for the recruitment of
ERK and MSK to the promoters of IE genes such as c-fos
and egr-1.
DISCUSSION
In this study, we have examined PICs associated with
promoters that contain a mitogen-responsive SRE. We
found that ERK and MSK are recruited to these
complexes in a mitogen-dependent fashion in vitro,
that the ternary complex factor Elk-1 recruits ERK
directly via its D-domain/KIM in vitro and is required
for recruitment of both ERK and MSK to the c-fos
promoter in vivo.
Validation ofin vitro PICformation on SREpromoters
Evidence that the PICs generated reﬂect the complexes
anticipated on SRE promoters included the sequence-
speciﬁc presence of Elk-1 and SRF, the recruitment of
basal factors, co-activators and co-repressors previously
reported to interact with SRF and Elk-1 (16–19,47,49).
Further evidence for functionality was provided by in vitro
transcription reactions. Although the absence of chroma-
tin precluded activator-dependent transcription, these
experiments conﬁrmed accurate initiation and transcrip-
tion by RNAPII on linear templates analogous to those
immobilized on beads. In addition, reporter assays
conﬁrmed that the single element promoters used for
these studies were functional in cells.
Many nuclear proteins have the potential to associate
with immobilized DNA molecules in vitro and are
potentially present as contaminants rather than valid
components of PICs, as earlier analyses of such complexes
have indicated (71,72) (our unpublished data; Vougier,S.
et al., manuscript in preparation). A speciﬁc concern
was the presence of basal transcription factors and
mediator components in PICs from unstimulated cells.
However, ChIP assays conﬁrmed that MED1 and MED23
occupy the c-fos promoter in serum-starved cells, in
agreement with our in vitro data and results on the
egr1 promoter (52). Set against that, our conclusions
that ERK and MSK associated selectively with SRE
PICs was based on their absence from DSE and
TATA promoters, their failure to associate without
mitogen stimulation (although present in unstimulated
Figure 7. Elk-1 knockdown prevents ERK and MSK recruitment to c-fos and egr-1 promoters. (a) HeLa cells were reverse transfected twice with
a combination of two Elk-1 siRNAs or mock transfected. After a further 48h cells were harvested, nuclear extracts prepared and analysed for
Elk-1 expression by SDS–PAGE and immunoblotting. (b) Native ( ) or Elk-1 knockdown HeLa cells (+) were serum starved or starved and
stimulated with TPA (100ngml
 1) for 15min. Binding of Elk-1 (lanes 9–12), ERK (lanes 13–16) and MSK (lanes 17–20) to the c-fos promoter was
determined by ChIP assay. (c) As in (b) except binding of Elk-1 (lanes 9–12), ERK (lanes 13–16) and MSK (lanes 17–20) to the egr-1 promoter
was determined.
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RSKs and corroboration by ChIP analyses of the c-fos
and egr1 promoters showing mitogen-induced recruitment
of both ERK and MSK. The presence of Elk-1 prior to
mitogen stimulation is consistent with earlier in vivo
footprint analyses (7,73) and appears to support the view
that a stable promoter architecture is established over the
SRE. However, as with previous work, the present study
does not exclude the possibility of protein turnover at
SRE promoters.
Although anticipated, this is the ﬁrst demonstration of
ERK recruitment to mitogen-responsive SRE promoters.
However, the presence of MSK chimes with earlier reports
of its involvement in dynamic histone H3S10 and H3S28
phosphorylation at IE gene promoters (57,58,67). We
conﬁrmed that H3S10 phosphorylation at the c-fos
promoter increased with mitogen stimulation and, in
addition, demonstrated its correlation with MSK recruit-
ment. Furthermore, the detection of MSK is consistent
with the interpretation that MSK rather than RSK2 fulﬁls
this role in response to mitogens at IE gene promoters
(55,57,66).
PromoterrecruitmentofERKthroughElk-1dockingdomains
Protein interactions by ERKs centre on the common
docking (CD) and extended docking (ED) domains
(74,75) and complementary kinase interaction motifs
have been found on ERK activators, substrates and
phosphatases alike (60,76,77). Elk-1 possesses a basic/
hydrophobic D domain/KIM and an FxFP motif, each
thought to be important for eﬃcient phosphorylation
of speciﬁc sites (15,63). The FxFP inﬂuences predomi-
nantly S383/9 phosphorylation (63) while phosphor-
ylation sites in Elk-1 for which the D domain/KIM is
critical are less well deﬁned, although reagents that
might resolve this issue exist (78). Stable associations
between substrates and ERK involving both the D
domain/KIM and FxFP motif have been demonstrated
(15,63,79) and a dual interaction model has been proposed
based on structural analyses of ERK and MKP3/
Elk-1-derived peptides whereby docking is initiated by
the D domain/KIM and subsequent favourable orienta-
tion of phosphorylation sites determined by the FxFP
motif (77).
Our data provide the ﬁrst demonstration of an
association between active ERK and Elk-1 bound in a
promoter complex. In this scenario, the D domain/KIM
was the dominant motif and the FxFP made a lesser
contribution to ERK recruitment. The severity of the
FxFP mutation was conﬁrmed by the virtual loss of S383
phosphorylation. Extrapolating from the model proposed
by Zhang et al. (77) to the context of a PIC, it is
conceivable that while ERK is associated with Elk-1 via D
domain/KIM-CD interactions, FxFP motifs present on
neighbouring proteins might engage ERK to promote
trans-phosphorylation events. However, the paucity of
Elk-1/ERK co-localization indicates that during active
transcription, associations between Elk-1 and ERK are
likely to be transient.
Nuclear co-localization of Elk-1and ERK is
limited or transient
The resolution and functional assignment of nuclear
structures is a complex undertaking. Sites of ongoing
transcription appear to be characterized by granular
clusters of RNAPII molecules distributed throughout the
nucleus yielding a speckled nuclear staining in proliferat-
ing (G1) cells (68,80). A punctate distribution has been
observed for a number of other factors and chromatin
modiﬁcations associated with active transcription, for
example H3S10 phosphorylation and H3K4 methyla-
tion (67,81). We observed comparable patterns of
nuclear distribution for both pElk-1 and pERK in
mitogen-stimulated cells. The degree of pERK-pElk-1
co-localization, however, was low, indicating that the bulk
of pERK and pElk-1 are not in complexes together
(Figure 6b). This may reﬂect either the limited number of
sites at which SRE promoters are transcribed or the
transient nature of Elk-1/ERK interactions in the nucleus.
In fact, the highest level of coincident staining was
observed between pERK and RNAPII pS5-CTD, suggest-
ing that ERK appears to associate to some extent with
initiating rather than elongating RNAPII. In light of these
and other recent ﬁndings, it seems feasible that the
association of MAPKs with transcription complexes
may be a more general characteristic of acutely regulated
promoters (22–27).
The recruitment of ERK by Elk-1 and the progesterone
receptor (27) as well as the observation of other MAPKs
at promoters (22–28) implies that there may be other ERK
targets within promoter complexes. In fact MED1 appears
to be phosphorylated by ERK, inﬂuencing its stability and
transactivation potential (29,31). However, several other
protein kinases are associated with PICs, including the
CTD kinase CDK7/cyclin H (present with MAT1 in
TFIIH), CDK8/cyclin C (present in the negative regula-
tory ARC/Mediator-like complex with Med230/240) and
Cdk9/cyclin T/K, part of the P-TEFb complex (positive
transcription elongation factor) responsible for the phos-
phorylation of the RNAPII CTD on S2, promoting
elongation (82). Hence, the identiﬁcation of bona ﬁde
ERK substrates in promoter complexes may not be
straightforward. For example, we observed promoter-
speciﬁc diﬀerences in pS5-CTD levels and conﬁrmed that
recombinant CTD can be phosphorylated by ERK2
in vitro (82,83), but phosphorylation of S5-CTD in PICs
was not blocked by ERK inhibitors (84,85). Further
analysis of proteins undergoing modiﬁcation in SRE PICs
is currently underway.
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ACKNOWLEDGEMENTS
We thank Robert Hipskind for plasmids, Marie Smith and
Ian Ward for assistance with confocal microscopy and
image analysis. This work was supported by grants to PES
from the BBSRC (C17917 and C19734). The Open Access
2604 Nucleic Acids Research, 2008, Vol. 36, No. 8publication charges for this article were waived by Oxford
University Press.
Conﬂict of interest statement. None declared.
REFERENCES
1. Shilatifard,A. (2006) Chromatin modiﬁcations by methylation and
ubiquitination: implications in the regulation of gene expression.
Annu. Rev. Biochem., 75, 243–269.
2. Kouzarides,T. (2007) Chromatin modiﬁcations and their function.
Cell, 128, 693–705.
3. Saha,A., Wittmeyer,J. and Cairns,B.R. (2006) Chromatin remodel-
ling: the industrial revolution of DNA around histones. Nat. Rev.
Mol. Cell Biol., 7, 437–447.
4. Schlessinger,J. (2000) Cell signaling by receptor tyrosine kinases.
Cell, 103, 211–225.
5. Miano,J.M., Long,X. and Fujiwara,K. (2007) Serum response
factor: master regulator of the actin cytoskeleton and contractile
apparatus. Am. J. Physiol. Cell Physiol., 292, C70–C81.
6. Hunt,T. and Sassone-Corsi,P. (2007) Riding tandem: circadian
clocks and the cell cycle. Cell, 129, 461–464.
7. Herrera,R.E., Shaw,P.E. and Nordheim,A. (1989) Occupation
of the c-fos serum response element in vivo by a multi-protein
complex is unaltered by growth factor induction. Nature, 340,
68–70.
8. Phatnani,H.P. and Greenleaf,A.L. (2006) Phosphorylation and
functions of the RNA polymerase II CTD. Genes Dev., 20,
2922–2936.
9. Clayton,A.L. and Mahadevan,L.C. (2003) MAP kinase-mediated
phosphoacetylation of histone H3 and inducible gene regulation.
FEBS Lett., 546, 51–58.
10. Pearson,G., Robinson,F., Beers Gibson,T., Xu,B.E.,
Karandikar,M., Berman,K. and Cobb,M.H. (2001) Mitogen-
activated protein (MAP) kinase pathways: regulation and
physiological functions. Endocrinol. Rev., 22, 153–183.
11. Turjanski,A.G., Vaque,J.P. and Gutkind,J.S. (2007) MAP kinases
and the control of nuclear events. Oncogene, 26, 3240–3253.
12. Sharrocks,A.D. (2001) The ETS-domain transcription factor family.
Nat. Rev. Mol. Cell Biol., 2, 827–837.
13. Shaw,P.E. and Saxton,J. (2003) Ternary complex factors: prime
nuclear targets for mitogen-activated protein kinases. Int. J.
Biochem. Cell Biol., 35, 1210–1226.
14. Buchwalter,G., Gross,C. and Wasylyk,B. (2004) Ets ternary
complex transcription factors. Gene, 324, 1–14.
15. Yang,S.-H., Shore,P., Willingham,N., Lakey,J.H. and
Sharrocks,A.D. (1999) The mechanism of phosphorylation-
inducible activation of the ETS-domain transcription factor Elk-1.
EMBO J., 18, 5666–5674.
16. Janknecht,R. and Nordheim,A. (1996) MAP kinase-dependent
transcriptional coactivation by Elk-1 and its cofactor CBP.
Biochem. Biophys. Res. Com., 228, 831–837.
17. Stevens,J.L., Cantin,G.T., Wang,G., Shevchenko,A. and Berk,A.J.
(2002) Transcription control by E1A and MAP kinase pathway via
Sur2 mediator subunit. Science, 296, 755–758.
18. Cantin,G.T., Stevens,J.L. and Berk,A.J. (2003) Domain-mediator
interactions promote transcription preinitiation complex
assembly on promoter DNA. Proc. Natl Acad. Sci. USA, 100,
12003–12008.
19. Li,Q.J., Yang,S.H., Maeda,Y., Sladek,F.M., Sharrocks,A.D. and
Martins-Green,M. (2003) MAP kinase phosphorylation-dependent
activation of Elk-1 leads to activation of the co-activator p300.
EMBO J., 22, 281–291.
20. Yang,S.H. and Sharrocks,A.D. (2005) PIASx acts as an Elk-1
coactivator by facilitating derepression. EMBO J., 24, 2161–2171.
21. Yang,S.H. and Sharrocks,A.D. (2006) PIASxalpha diﬀerentially
regulates the amplitudes of transcriptional responses following
activation of the ERK and p38 MAPK pathways. Mol. Cell, 22,
477–487.
22. Alepuz,P.M., Jovanovic,A., Reiser,V. and Ammerer,G. (2001)
Stress-induced map kinase Hog1 is part of transcription activation
complexes. Mol. Cell, 7, 767–777.
23. Proft,M. and Struhl,K. (2002) Hog1 kinase converts the Sko1-
Cyc8-Tup1 repressor complex into an activator that recruits SAGA
and SWI/SNF in response to osmotic stress. Mol. Cell, 9,
1307–1317.
24. Bardwell,L., Cook,J.G., Voora,D., Baggott,D.M., Martinez,A.R.
and Thorner,J. (1998) Repression of yeast Ste12 transcription factor
by direct binding of unphosphorylated Kss1 MAPK and its
regulation by the Ste7 MEK. Genes Dev., 12, 2887–2898.
25. Pokholok,D.K., Zeitlinger,J., Hannett,N.M., Reynolds,D.B. and
Young,R.A. (2006) Activated signal transduction kinases frequently
occupy target genes. Science, 313, 533–536.
26. Simone,C., Forcales,S.V., Hill,D.A., Imbalzano,A.N., Latella,L.
and Puri,P.L. (2004) p38 pathway targets SWI-SNF chromatin-
remodeling complex to muscle-speciﬁc loci. Nat. Genet., 36,
738–743.
27. Vicent,G.P., Ballare,C., Nacht,A.S., Clausell,J., Subtil-
Rodriguez,A., Quiles,I., Jordan,A. and Beato,M. (2006) Induction
of progesterone target genes requires activation of Erk and
Msk kinases and phosphorylation of histone H3. Mol. Cell, 24,
367–381.
28. Edmunds,J.W. and Mahadevan,L.C. (2006) Cell signaling. Protein
kinases seek close encounters with active genes. Science, 313,
449–451.
29. Misra,P., Owuor,E.D., Li,W., Yu,S., Qi,C., Meyer,K., Zhu,Y.J.,
Rao,M.S., Kong,A.N. and Reddy,J.K. (2002) Phosphorylation of
transcriptional coactivator peroxisome proliferator-activated recep-
tor (PPAR)-binding protein (PBP). Stimulation of transcriptional
regulation by mitogen-activated protein kinase. J. Biol. Chem., 277,
48745–48754.
30. De Nadal,E., Zapater,M., Alepuz,P.M., Sumoy,L., Mas,G. and
Posas,F. (2004) The MAPK Hog1 recruits Rpd3 histone deacetylase
to activate osmoresponsive genes. Nature, 427, 370–374.
31. Pandey,P.K., Udayakumar,T.S., Lin,X., Sharma,D., Shapiro,P.S.
and Fondell,J.D. (2005) Activation of TRAP/Mediator subunit
TRAP220/Med1 is regulated by mitogen-activated protein
kinase-dependent phosphorylation. Mol. Cell Biol., 25,
10695–10710.
32. Dignam,J.D., Lebovitz,R.M. and Roeder,R.G. (1983) Accurate
transcription initiation by RNA polymerase II in a soluble
extract from isolated mammalian nuclei. Nucleic Acids Res., 11,
1475–1489.
33. Li,L. and Shaw,P.E. (2006) Elevated activity of STAT3C due to
higher DNA-binding aﬃnity of phosphotyrosine dimer rather than
covalent dimer formation. J. Biol. Chem., 281, 33172–33181.
34. Hipskind,R.A. and Nordheim,A. (1991) Functional dissection
in vitro of the human c-fos promoter. J. Biol. Chem., 266,
19583–19592.
35. Sadowski,I., Ma,J., Triezenberg,S. and Ptashne,M. (1988) GAL4-
VP16 is an unusually potent transcriptional activator. Nature, 335,
563–564.
36. Drewett,V., Muller,S., Goodall,J. and Shaw,P.E. (2000) Dimer
formation by ternary complex factor Elk-1. J. Biol. Chem., 275,
1757–1762.
37. Gille,H., Kortenjann,M., Thomae,O., Moomaw,C., Slaughter,C.,
Cobb,M.H. and Shaw,P.E. (1995) ERK phosphorylation
potentiates ELK-1-mediated ternary complex formation and
transactivation. EMBO J., 14, 951–962.
38. Khokhlatchev,A.V., Xu,S., English,J., Wu,P., Schaefer,E. and
Cobb,M.H. (1997) Reconstitution of mitogen-activated protein
kinase phosphorylation cascades in bacteria. Eﬃcient synthesis of
active protein kinases. J. Biol. Chem., 272, 11057–11062.
39. Shang,Y., Hu,X., DiRenzo,J., Lazar,M.A. and Brown,M. (2000)
Cofactor dynamics and suﬃciency in estrogen receptor-regulated
transcription. Cell, 103, 843–852.
40. Vickers,E.R., Kasza,A., Kurnaz,I.A., Seifert,A., Zeef,L.A.,
O’donnell,A., Hayes,A. and Sharrocks,A.D. (2004) Ternary com-
plex factor-serum response factor complex-regulated gene activity is
required for cellular proliferation and inhibition of apoptotic cell
death. Mol. Cell Biol., 24, 10340–10351.
41. Schro ¨ ter,H., Mueller,C.G., Meese,K. and Nordheim,A. (1990)
Synergism in ternary complex formation between the dimeric
glycoprotein p67SRF, polypeptide p62TCF and the c-fos serum
response element. EMBO J., 9, 1123–1130.
Nucleic Acids Research, 2008, Vol. 36, No. 8 260542. Graham,R. and Gilman,M. (1991) Distinct protein targets for
signals acting at the c-fos serum response element. Science, 251,
189–192.
43. Hill,C.S., Wynne,J. and Treisman,R. (1995) The Rho family
GTPasses RhoA, Rac1 and CDC42Hs regulate transcriptional
activation by SRF. Cell, 81, 1159–1170.
44. Miralles,F., Posern,G., Zaromytidou,A.I. and Treisman,R. (2003)
Actin dynamics control SRF activity by regulation of its coactivator
MAL. Cell, 113, 329–342.
45. Hipskind,R.A., Rao,V.N., Mueller,C.G.F., Reddy,E.S.P. and
Nordheim,A. (1991) Ets-related protein Elk-1 is homologous to the
c-fos regulatory factor p62TCF. Nature, 354, 531–534.
46. Criqui-Filipe,P., Ducret,C., Maira,S.M. and Wasylyk,B. (1999)
Net, a negative Ras-switchable TCF, contains a second
inhibition domain, the CID, that mediates repression through
interactions with CtBP and de-acetylation. EMBO J., 18,
3392–3403.
47. Yang,S.H. and Sharrocks,A.D. (2004) SUMO promotes
HDAC-mediated transcriptional repression. Mol. Cell, 13, 611–617.
48. Yang,S.H., Vickers,E., Brehm,A., Kouzarides,T. and
Sharrocks,A.D. (2001) Temporal recruitment of the mSin3A-histone
deacetylase corepresor complex to the ETS domain transcription
factor Elk-1. Mol. Cell Biol., 21, 2802–2814.
49. Joliot,V., Demma,M. and Prywes,R. (1995) Interaction with RAP74
subunit of TFIIF is required for transcriptional activation by serum
response factor. Nature, 373, 632–635.
50. Lewis,B.A. and Reinberg,D. (2003) The mediator coactivator
complex: functional and physical roles in transcriptional regulation.
J. Cell Sci., 116, 3667–3675.
51. Malik,S. and Roeder,R.G. (2005) Dynamic regulation of pol II
transcription by the mammalian Mediator complex. Trends
Biochem. Sci., 30, 256–263.
52. Wang,G., Balamotis,M.A., Stevens,J.L., Yamaguchi,Y., Handa,H.
and Berk,A.J. (2005) Mediator requirement for both recruitment
and postrecruitment steps in transcription initiation. Mol. Cell, 17,
683–694.
53. Chen,R.H., Sarnecki,C. and Blenis,J. (1992) Nuclear localization
and regulation of erk- and rsk-encoded protein kinases. Mol. Cell
Biol., 12, 915–927.
54. Pouyssegur,J. and Lenormand,P. (2003) Fidelity and spatio-
temporal control in MAP kinase (ERKs) signalling. Eur. J.
Biochem., 270, 3291–3299.
55. Sassone-Corsi,P., Mizzen,C.A., Cheung,P., Crosio,C., Monaco,L.,
Jacquot,S., Hanauer,A. and Allis,C.D. (1999) Requirement of Rsk-2
for epidermal growth factor-activated phosphorylation of histone
H3. Science, 285, 886–891.
56. Bruning,J.C., Gillette,J.A., Zhao,Y., Bjorbaeck,C., Kotzka,J.,
Knebel,B., Avci,H., Hanstein,B., Lingohr,P., Moller,D.E. et al.
(2000) Ribosomal subunit kinase-2 is required for growth factor-
stimulated transcription of the c-Fos gene. Proc. Natl Acad. Sci.
USA, 97, 2462–2467.
57. Soloaga,A., Thomson,S., Wiggin,G.R., Rampersaud,N.,
Dyson,M.H., Hazzalin,C.A., Mahadevan,L.C. and Arthur,J.S.
(2003) MSK2 and MSK1 mediate the mitogen- and stress-induced
phosphorylation of histone H3 and HMG-14. EMBO J., 22,
2788–2797.
58. Duncan,E.A., Anest,V., Cogswell,P. and Baldwin,A.S. (2006) The
kinases MSK1 and MSK2 are required for epidermal growth factor-
induced, but not tumor necrosis factor-induced, histone H3 Ser10
phosphorylation. J. Biol. Chem., 281, 12521–12525.
59. Trivier,E., De Cesare,D., Jacquot,S., Pannetier,S., Zackai,E.,
Young,I., Mandel,J.L., Sassone-Corsi,P. and Hanauer,A. (1996)
Mutations in the kinase Rsk-2 associated with Coﬃn-Lowry
syndrome. Nature, 384, 567–570.
60. Sharrocks,A.D., Yang,S.H. and Galanis,A. (2000) Docking
domains and substrate-speciﬁcity determination for MAP kinases.
Trends Biochem. Sci., 25, 448–453.
61. Tanoue,T. and Nishida,E. (2002) Docking interactions in the
mitogen-activated protein kinase cascades. Pharmacol. Ther., 93,
193–202.
62. Yang,S.H., Yates,P.R., Whitmarsh,A.J., Davis,R.J. and
Sharrocks,A.D. (1998) The Elk-1 ETS-domain transcription factor
contains a mitogen-activated protein kinase targeting motif. Mol.
Cell Biol., 18, 710–720.
63. Jacobs,D., Glossip,D., Xing,H., Muslin,A.J. and Kornfeld,K.
(1999) Multiple docking sites on substrate proteins form a modular
system that mediates recognition by ERK MAP kinase. Genes Dev.,
13, 163–175.
64. Aprelikova,O., Wood,M., Tackett,S., Chandramouli,G.V. and
Barrett,J.C. (2006) Role of ETS transcription factors in the
hypoxia-inducible factor-2 target gene selection. Cancer Res., 66,
5641–5647.
65. Zhou,J., Hu,G. and Herring,B.P. (2005) Smooth muscle-speciﬁc
genes are diﬀerentially sensitive to inhibition by Elk-1. Mol. Cell
Biol., 25, 9874–9885.
66. Cheung,P., Tanner,K.G., Cheung,W.L., Sassone-Corsi,P.,
Denu,J.M. and Allis,C.D. (2000) Synergistic coupling of histone H3
phosphorylation and acetylation in response to epidermal growth
factor stimulation. Mol. Cell, 5, 905–915.
67. Dyson,M.H., Thomson,S., Inagaki,M., Goto,H., Arthur,S.J.,
Nightingale,K., Iborra,F.J. and Mahadevan,L.C. (2005) MAP
kinase-mediated phosphorylation of distinct pools of histone H3at
S10 or S28 via mitogen- and stress-activated kinase 1/2. J. Cell Sci.,
118, 2247–2259.
68. Grande,M.A., van der Kraan,I., de Jong,L. and van Driel,R. (1997)
Nuclear distribution of transcription factors in relation to sites
of transcription and RNA polymerase II. J. Cell Sci., 110,
1781–1791.
69. van Steensel,B., van Binnendijk,E.P., Hornsby,C.D., van der
Voort,H.T., Krozowski,Z.S., de Kloet,E.R. and van Driel,R. (1996)
Partial colocalization of glucocorticoid and mineralocorticoid
receptors in discrete compartments in nuclei of rat hippocampus
neurons. J. Cell Sci., 109, 787–792.
70. Elbashir,S.M., Harborth,J., Lendeckel,W., Yalcin,A., Weber,K. and
Tuschl,T. (2001) Duplexes of 21-nucleotide RNAs mediate
RNA interference in cultured mammalian cells. Nature, 411,
494–498.
71. Drewett,V., Molina,H., Millar,A., Muller,S., von Hesler,F. and
Shaw,P.E. (2001) DNA-bound transcription factor complexes
analysed by mass-spectrometry: binding of novel proteins to the
human c-fos SRE and related sequences. Nucleic Acids Res., 29,
479–487.
72. Ranish,J.A., Yi,E.C., Leslie,D.M., Purvine,S.O., Goodlett,D.R.,
Eng,J. and Aebersold,R. (2003) The study of macromolecular
complexes by quantitative proteomics. 33, 349–355.
73. Ko ¨ nig,H. (1991) Cell-type speciﬁc multiprotein complex formation
over the c-fos serum response element in vivo: ternary complex
formation is not required for the induction of c-fos. Nucleic Acids
Res., 19, 3607–3611.
74. Tanoue,T., Adachi,M., Moriguchi,T. and Nishida,E. (2000) A
conserved docking motif in MAP kinases common to substrates,
activators and regulators. Nat. Cell Biol., 2, 110–116.
75. Tanoue,T., Maeda,R., Adachi,M. and Nishida,E. (2001)
Identiﬁcation of a docking groove on ERK and p38 MAP kinases
that regulates the speciﬁcity of docking interactions. EMBO J., 20,
466–479.
76. Tanoue,T. and Nishida,E. (2003) Molecular recognitions in the
MAP kinase cascades. Cell Signal., 15, 455–462.
77. Zhang,J., Zhou,B., Zheng,C.F. and Zhang,Z.Y. (2003) A bipartite
mechanism for ERK2 recognition by its cognate regulators and
substrates. J. Biol. Chem., 278, 29901–29912.
78. Cruzalegui,F.H., Cano,E. and Treisman,R. (1999) ERK activation
induces phosphorylation of Elk-1at multiple S/T-P motifs to high
stoichiometry. Oncogene, 18, 7948–7957.
79. Ducret,C., Maira,S.M., Lutz,Y. and Wasylyk,B. (2000) The ternary
complex factor Net contains two distinct elements that mediate
diﬀerent responses to MAP kinase signalling cascades. Oncogene,
19, 5063–5072.
80. Wei,X., Somanathan,S., Samarabandu,J. and Berezney,R. (1999)
Three-dimensional visualization of transcription sites and their
association with splicing factor-rich nuclear speckles. J. Cell Biol.,
146, 543–558.
81. Santos-Rosa,H., Schneider,R., Bannister,A.J., Sherriﬀ,J.,
Bernstein,B.E., Emre,N.C., Schreiber,S.L., Mellor,J. and
2606 Nucleic Acids Research, 2008, Vol. 36, No. 8Kouzarides,T. (2002) Active genes are tri-methylated at K4 of
histone H3. Nature, 419, 407–411.
82. Loyer,P., Trembley,J.H., Katona,R., Kidd,V.J. and Lahti,J.M.
(2005) Role of CDK/cyclin complexes in transcription and RNA
splicing. Cell Signal., 17, 1033–1051.
83. Bonnet,F., Vigneron,M., Bensaude,O. and Dubois,M.F. (1999)
Transcription-independent phosphorylation of the RNA polymerase
II C-terminal domain (CTD) involves ERK kinases (MEK1/2).
Nucleic Acids Res., 27, 4399–4404.
84. Hancock,C.N., Macias,A., Lee,E.K., Yu,S.Y., Mackerell,A.D.J.
and Shapiro,P. (2005) Identiﬁcation of novel extracellular signal-
regulated kinase docking domain inhibitors. J. Med. Chem., 48,
4586–4595.
85. Chen,F., Hancock,C.N., Macias,A.T., Joh,J., Still,K., Zhong,S.,
MacKerell,A.D.,Jr. and Shapiro,P. (2006) Characterization of ATP-
independent ERK inhibitors identiﬁed through in silico analysis of
the active ERK2 structure. Bioorg. Med. Chem. Lett., 16,
6281–6287.
Nucleic Acids Research, 2008, Vol. 36, No. 8 2607